XML 37 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Guarantors (Tables)
9 Months Ended
Jul. 27, 2012
Schedule of Condensed Consolidating Balance Sheet

Condensed Consolidating Balance Sheet as of July 27, 2012.

 

(In thousands)                              
    Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

 

Assets

         

 

Current Assets

         

Cash and cash equivalents

  $ 33,326      $ 11,010      $ 168,737      $ 0      $ 213,073   

Cash in escrow

    5,014        0        0        0        5,014   

Accounts receivable, net

    146        121,839        211,830        0        333,815   

Inventories

    0        160,973        249,542        0        410,515   

Income tax refundable

    0        10,409        0        0        10,409   

Deferred income tax benefits

    23,342        714        22,022        0        46,078   

Prepaid expenses

    95        5,399        18,378        0        23,872   

Other current assets

    131        439        2,081        0        2,651   

 

 

Total Current Assets

    62,054        310,783        672,590        0        1,045,427   

 

Property, Plant &
Equipment, Net

    3,026        162,959        189,066        0        355,051   

Goodwill

    0        315,127        761,747        0        1,076,874   

Intangibles, Net

    0        129,742        478,674        0        608,416   

Debt Issuance Costs, Net

    7,895        0        1,399        0        9,294   

Deferred Income
Tax Benefits

    28,051        (150 )      60,307        0        88,208   

Other Assets

    8,209        1,616        8,931        0        18,756   

Amounts Due From (To)
Subsidiaries

    0        509,512        0        (509,512 )      0   

Investment in Subsidiaries

    2,411,673        1,134,042        248,315        (3,794,030 )      0   

 

 

Total Assets

  $      2,520,908      $      2,563,631      $      2,421,029      $     (4,303,542 )    $      3,202,026   

 

 
(In thousands)                              
    Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

Liabilities and Shareholders’ Equity

         

 

Current Liabilities

         

Accounts payable

  $ 863      $ 26,116      $ 82,957      $ 0      $ 109,936   

Accrued liabilities

    26,557        77,588        164,744        0        268,889   

Credit facilities

    0        0        127        0        127   

Current maturities of
long-term debt

    0        184        12,337        0        12,521   

Deferred income tax
liabilities

    200        (1 )      3,304        0        3,503   

Federal and foreign
income taxes

    9,075        (16,067 )      20,705        0        13,713   

 

 

Total Current Liabilities

    36,695        87,820        284,174        0        408,689   

 

Credit Facilities

    300,000        0        0        0        300,000   

Long-Term Debt, Net

    429,182        44,152        146,419        0        619,753   

Deferred Income Tax
Liabilities

    50,056        (8 )      158,654        0        208,702   

Pension and Post-
Retirement Obligations

    17,246        25,392        47,132        0        89,770   

Other Liabilities

    4,655        3,794        25,731        0        34,180   

Amounts Due To (From)
Subsidiaries

    142,142        0        475,782        (617,924 )      0   

Shareholders’ Equity

    1,540,932        2,402,481        1,283,137        (3,685,618 )      1,540,932   

 

 

Total Liabilities and
Shareholders’ Equity

  $      2,520,908      $      2,563,631      $      2,421,029      $     (4,303,542 )    $      3,202,026   

 

 

Condensed Consolidating Balance Sheet as of October 28, 2011.

 

(In thousands)                              
                Non-              
          Guarantor     Guarantor              
    Parent         Subsidiaries         Subsidiaries       Eliminations     Total  

Assets

         

 

Current Assets

         

Cash and cash equivalents

  $ 49,837      $ 13,450      $ 121,748      $ 0      $ 185,035   

Cash in escrow

    5,011        0        0        0        5,011   

Accounts receivable, net

    158        137,927        231,741        0        369,826   

Inventories

    0        143,866        258,682        0        402,548   

Income tax refundable

    0        0        2,857        0        2,857   

Deferred income tax benefits

    25,585        1,574        21,092        0        48,251   

Prepaid expenses

    59        5,006        14,180        0        19,245   

Other current assets

    140        344        6,056        0        6,540   

 

 

Total Current Assets

    80,790        302,167        656,356        0        1,039,313   

Property, Plant &

         

Equipment, Net

    1,109        161,297        206,010        0        368,416   

Goodwill

    0        313,788        849,937        0        1,163,725   

Intangibles, Net

    0        140,590        553,325        0        693,915   

Debt Issuance Costs, Net

    9,033        0        1,662        0        10,695   

Deferred Income Tax

         

Benefits

    27,925        125        51,555        0        79,605   

Other Assets

    10,307        2,321        10,289        0        22,917   

Amounts Due From (To)

         

Subsidiaries

    350,407        482,330        0        (832,737 )      0   

Investment in Subsidiaries

    1,953,823        624,856        321,170        (2,899,849 )      0   

 

 

Total Assets

  $      2,433,394      $      2,027,474      $      2,650,304      $     (3,732,586 )    $      3,378,586   

 

 
(In thousands)                              
                Non-              
          Guarantor     Guarantor              
    Parent         Subsidiaries         Subsidiaries       Eliminations     Total  

Liabilities and Shareholders’ Equity

  

       

 

Current Liabilities

         

Accounts payable

  $ 812      $ 26,525      $ 92,551      $ 0      $ 119,888   

Accrued liabilities

    18,587        79,524        172,311        0        270,422   

Credit facilities

    0        0        5,000        0        5,000   

Current maturities of

         

long-term debt

    0        211        11,384        0        11,595   

Deferred income tax

         

liabilities

    238        (1 )      9,301        0        9,538   

Federal and foreign

         

income taxes

    (1,326 )      (25,185 )      28,429        0        1,918   

 

 

Total Current Liabilities

    18,311        81,074        318,976        0        418,361   

Credit Facilities

    360,000        0        0        0        360,000   

Long-Term Debt, Net

    426,354        44,289        189,385        0        660,028   

Deferred Income Tax

         

Liabilities

    32,959        21,971        183,779        0        238,709   

Pension and Post-

         

Retirement Obligations

    17,849        38,335        51,693        0        107,877   

Other Liabilities

    4,003        8,549        7,141        0        19,693   

Amounts Due To (From)

         

Subsidiaries

    0        0        444,820        (444,820 )      0   

Shareholders’ Equity

    1,573,918        1,833,256        1,454,510        (3,287,766 )      1,573,918   

 

 

Total Liabilities and

         

Shareholders’ Equity

  $      2,433,394      $      2,027,474      $      2,650,304      $     (3,732,586 )    $      3,378,586   

 

 
Schedule of Condensed Consolidating Statement of Operations

Condensed Consolidating Statement of Operations for the three month period ended July 27, 2012.

 

(In thousands)                              
    Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

 

Net Sales

  $ 0      $ 227,022      $ 260,229      $ (1,302 )    $ 485,949   

Cost of Sales

    0        144,787        170,368        (1,302 )      313,853   

 

 
    0        82,235        89,861        0        172,096   

Expenses

         

Selling, general
and administrative

    0        35,862        56,007        0        91,869   

Research, development
and engineering

    0        13,062        14,136        0        27,198   

Gain on settlement of
contingency

    0        0        0        0        0   

Goodwill impairment

    0        0        52,169        0        52,169   

Other income

    0        0        (1,263 )      0        (1,263 ) 

 

 

Total Expenses

    0        48,924        121,049        0        169,973   

 

 

 

Operating Earnings from
Continuing Operations

    0        33,311        (31,188 )      0        2,123   

Interest Income

    (3,574 )      (5,090 )      (14,319 )      22,874        (109 ) 

Interest Expense

    8,648        7,396        18,989        (22,874 )      12,159   

Loss on Extinguishment
of Debt

    0        0        0        0        0   

 

 

Income (Loss) from
Continuing Operations
Before Taxes

    (5,074 )      31,005        (35,858 )      0        (9,927 ) 

Income Tax Expense
(Benefit)

    (4,058 )      22,476        (11,455 )      0        6,963   

 

 

Income (Loss) from
Continuing Operations
Including Noncontrolling
Interests

    (1,016 )      8,529        (24,403 )      0        (16,890 ) 

Income Attributable to
Noncontrolling Interests

    0        0        (214 )      0        (214 ) 

 

 

Income (Loss) from
Continuing Operations
Attributable to Esterline

    (1,016 )      8,529        (24,617 )      0        (17,104 ) 

Loss from Discontinued
Operations Attributable
to Esterline, Net of Tax

    0        0        0        0        0   

Equity in Net Income of
Consolidated Subsidiaries

    (16,088 )      2,080        (50 )      14,058        0   

 

 

Net Earnings (Loss)
Attributable to Esterline

  $         (17,104 )    $           10,609      $         (24,667 )    $           14,058      $         (17,104 ) 

 

 

 

Condensed Consolidating Statement of Operations for the nine month period ended July 27, 2012.

 

(In thousands)                              
    Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

 

Net Sales

  $ 0      $ 670,767      $ 793,626      $ (2,731 )    $ 1,461,662   

Cost of Sales

    0        419,969        529,724        (2,731 )      946,962   

 

 
    0        250,798        263,902        0        514,700   

Expenses

         

Selling, general
and administrative

    0        107,639        177,877        0        285,516   

Research, development
and engineering

    0        38,080        45,058        0        83,138   

Gain on settlement of
contingency

    0        0        (11,891 )      0        (11,891 ) 

Goodwill impairment

    0        0        52,169        0        52,169   

Other income

    0        0        (1,263 )      0        (1,263 ) 

 

 

Total Expenses

    0        145,719        261,950        0        407,669   

 

 

 

Operating Earnings from
Continuing Operations

    0        105,079        1,952        0        107,031   

Interest Income

    (10,559 )      (12,468 )      (47,717 )      70,424        (320 ) 

Interest Expense

    26,311        20,613        58,671        (70,424 )      35,171   

Loss on Extinguishment
of Debt

    0        0        0        0        0   

 

 

 

Income (Loss) from
Continuing Operations
Before Taxes

    (15,752 )      96,934        (9,002 )      0        72,180   

Income Tax Expense
(Benefit)

    (6,087 )      32,840        (6,076 )      0        20,677   

 

 

Income (Loss) from
Continuing Operations
Including Noncontrolling
Interests

    (9,665 )      64,094        (2,926 )      0        51,503   

Income Attributable to
Noncontrolling Interests

    0        0        (628 )      0        (628 ) 

 

 

Income (Loss) from
Continuing Operations
Attributable to Esterline

    (9,665 )      64,094        (3,554 )      0        50,875   

Loss from Discontinued
Operations Attributable
to Esterline, Net of Tax

    0        0        0        0        0   

Equity in Net Income of
Consolidated Subsidiaries

    60,540        10,791        (140 )      (71,191 )      0   

 

 

Net Earnings (Loss)
Attributable to Esterline

  $           50,875      $           74,885      $            (3,694 )    $         (71,191 )    $           50,875   

 

 

Condensed Consolidating Statement of Operations for the three month period ended July 29, 2011.

 

(In thousands)                              
                Non-              
          Guarantor     Guarantor              
    Parent         Subsidiaries         Subsidiaries       Eliminations     Total  

Net Sales

  $ 0      $ 215,058      $ 195,162      $ (708 )    $ 409,512   

Cost of Sales

    0        141,994        124,687        (708 )      265,973   

 

 
    0        73,064        70,475        0        143,539   

Expenses

         

Selling, general

         

and administrative

    0        35,803        40,615        0        76,418   

Research, development

         

and engineering

    0        8,973        14,102        0        23,075   

Gain on settlement of

         

contingency

    0        0        0        0        0   

Goodwill impairment

    0        0        0        0        0   

Other income

    0        0        (6,366 )      0        (6,366 ) 

 

 

Total Expenses

    0        44,776        48,351        0        93,127   

 

 

Operating Earnings from

         

Continuing Operations

    0        28,288        22,124        0        50,412   

Interest Income

    (3,748 )      (794 )      (6,908 )      10,792        (658 ) 

Interest Expense

    8,628        5,326        7,124        (10,792 )      10,286   

Loss on Extinguishment

         

of Debt

    0        0        0        0        0   

 

 

Income (Loss) from

         

Continuing Operations

         

Before Taxes

    (4,880 )      23,756        21,908        0        40,784   

Income Tax Expense

         

(Benefit)

    (1,250 )      1,640        2,431        0        2,821   

 

 

Income (Loss) from

         

Continuing Operations

         

Including Noncontrolling

         

Interests

    (3,630 )      22,116        19,477        0        37,963   

Income Attributable to

         

Noncontrolling Interests

    0        0        (222 )      0        (222 ) 

 

 

Income (Loss) from

         

Continuing Operations

         

Attributable to Esterline

    (3,630 )      22,116        19,255        0        37,741   

Loss from Discontinued

         

Operations Attributable

         

to Esterline, Net of Tax

    0        (46 )      0        0        (46 ) 

Equity in Net Income of

         

Consolidated Subsidiaries

    41,325        9,492        (1,365 )      (49,452 )      0   

 

 

Net Earnings (Loss)

         

Attributable to Esterline

  $           37,695      $           31,562      $           17,890      $          (49,452 )    $           37,695   

 

 

Condensed Consolidating Statement of Operations for the nine month period ended July 29, 2011.

 

(In thousands)                              
                Non-              
          Guarantor     Guarantor              
    Parent         Subsidiaries         Subsidiaries        Eliminations     Total  

Net Sales

  $ 0      $ 640,539      $ 576,745      $ (1,696 )    $ 1,215,588   

Cost of Sales

    0        410,499        370,177        (1,696 )      778,980   

 

 
    0        230,040        206,568        0        436,608   

Expenses

         

Selling, general

         

and administrative

    0        99,909        115,010        0        214,919   

Research, development

         

and engineering

    0        26,891        37,054        0        63,945   

Gain on settlement of

         

contingency

    0        0        0        0        0   

Goodwill impairment

    0        0        0        0        0   

Other income

    0        0        (6,366 )      0        (6,366 ) 

 

 

Total Expenses

    0        126,800        145,698        0        272,498   

 

 

Operating Earnings from

         

Continuing Operations

    0        103,240        60,870        0        164,110   

Interest Income

    (10,770 )      (2,053 )      (18,007 )      29,402        (1,428 ) 

Interest Expense

    24,348        15,413        18,022        (29,402 )      28,381   

Loss on Extinguishment

         

of Debt

    831        0        0        0        831   

 

 

Income (Loss) from

         

Continuing Operations

         

Before Taxes

    (14,409 )      89,880        60,855        0        136,326   

Income Tax Expense

         

(Benefit)

    (3,527 )      12,635        13,215        0        22,323   

 

 

Income (Loss) from

         

Continuing Operations

         

Including Noncontrolling

         

Interests

    (10,882 )      77,245        47,640        0        114,003   

Income Attributable to

         

Noncontrolling Interests

    0        0        (328 )      0        (328 ) 

 

 

Income (Loss) from

         

Continuing Operations

         

Attributable to Esterline

    (10,882 )      77,245        47,312        0        113,675   

Loss from Discontinued

         

Operations Attributable

         

to Esterline, Net of Tax

    0        (75 )      0        0        (75 ) 

Equity in Net Income of

         

Consolidated Subsidiaries

    124,482        22,354        1,127        (147,963 )      0   

 

 

Net Earnings (Loss)

         

Attributable to Esterline

  $         113,600      $        99,524      $        48,439      $     (147,963 )    $         113,600   

 

 
Schedule of Condensed Consolidating Statement of Cash Flows

Condensed Consolidating Statement of Cash Flows for the nine month period ended July 27, 2012.

 

(In thousands)                              
    Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

 

Cash Flows Provided (Used) by Operating Activities

  

     

Net earnings (loss) including
noncontrolling interests

  $           51,503      $           74,885      $           (3,694 )    $         (71,191 )    $           51,503   

Depreciation & amortization

    0        28,556        50,709        0        79,265   

Deferred income taxes

    19,199        (20,844 )      (17,991 )      0        (19,636 ) 

Share-based compensation

    0        3,344        4,342        0        7,686   

Gain on settlement of
contingency

    0        0        (11,891 )      0        (11,891 ) 

Goodwill impairment

    0        0        52,169        0        52,169   

Working capital changes, net
of effect of acquisitions
Accounts receivable

    12        16,088        4,875        0        20,975   

Inventories

    0        (17,107 )      (10,387 )      0        (27,494 ) 

Prepaid expenses

    (36 )      (393 )      (4,994 )      0        (5,423 ) 

Other current assets

    9        (95 )      274        0        188   

Accounts payable

    51        (409 )      (2,108 )      0        (2,466 ) 

Accrued liabilities

    7,489        (2,201 )      11,635        0        16,923   

Federal & foreign
income taxes

    8,148        (1,745 )      (4,252 )      0        2,151   

Other liabilities

    5,718        (17,698 )      (3,094 )      0        (15,074 ) 

Other, net

    (83 )      494        1,960        0        2,371   

 

 
    91,010        62,875        67,553        (71,191 )      151,247   

 

Cash Flows Provided (Used) by Investing Activities

  

     

Purchases of capital assets

    (1,466 )      (18,728 )      (19,262 )      0        (39,456 ) 

Proceeds from sale
of capital assets

    0        464        675        0        1,139   

Escrow deposit

    0        0        0        0        0   

Acquisitions, net of
cash acquired

    0        0        0        0        0   

 

 
    (1,466 )      (18,264 )      (18,587 )      0        (38,317 ) 
(In thousands)                              
    Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

 

Cash Flows Provided (Used) by Financing Activities

  

     

Proceeds provided by stock
issuance under employee
stock plans

    7,331        0        0        0                  7,331   

Excess tax benefits from
stock options exercised

    221        0        0        0        221   

Dividends paid to non-
controlling interests

    0        0        0        0        0   

Debt and other issuance costs

    0        0        0        0        0   

Proceeds from credit facilities

    0        0        127        0        127   

Proceeds from issuance of
long-term debt

    0        0        0        0        0   

Repayment of long-term debt
and credit facilities

    (60,000 )      (306 )      (43,825 )      0        (104,131 ) 

Proceeds from government
assistance

    0        0        17,203        0        17,203   

Net change in intercompany
financing

    (54,603 )      (46,752 )                30,164        71,191        0   

 

 
    (107,051 )      (47,058 )      3,669              71,191        (79,249 ) 

 

Effect of foreign exchange
rates on cash

    (4 )      7        (5,646 )      0        (5,643 ) 

 

 

 

Net increase (decrease) in
cash and cash equivalents

    (16,511 )      (2,440 )      46,989        0        28,038   

Cash and cash equivalents
– beginning of year

    49,837        13,450        121,748        0        185,035   

 

 

Cash and cash equivalents
– end of year

  $           33,326      $           11,010      $ 168,737      $ 0      $ 213,073   

 

 

Condensed Consolidating Statement of Cash Flows for the nine month period ended July 29, 2011.

 

(In thousands)                              
                Non-              
          Guarantor     Guarantor              
    Parent         Subsidiaries         Subsidiaries        Eliminations     Total  

Cash Flows Provided (Used) by Operating Activities

  

     

Net earnings (loss) including

         

noncontrolling interests

  $         113,928      $           99,524      $           48,439      $        (147,963 )    $         113,928   

Depreciation & amortization

    0        26,389        30,349        0        56,738   

Deferred income taxes

    8,727        (18 )      (7,886 )      0        823   

Share-based compensation

    0        2,643        3,138        0        5,781   

Gain on settlement of

         

contingency

    0        0        0        0        0   

Goodwill impairment

    0        0        0        0        0   

Working capital changes, net

         

of effect of acquisitions

         

Accounts receivable

    262        9,055        25,308        0        34,625   

Inventories

    0        (16,564 )      (18,360 )      0        (34,924 ) 

Prepaid expenses

    (71 )      355        (1,812 )      0        (1,528 ) 

Other current assets

    (26 )      (96 )      (1,443 )      0        (1,565 ) 

Accounts payable

    (95 )      833        (355 )      0        383   

Accrued liabilities

    5,399        (318 )      (3,308 )      0        1,773   

Federal & foreign

         

income taxes

    3,477        (4,591 )      4,691        0        3,577   

Other liabilities

    (632 )      (17,956 )      (1,524 )      0        (20,112 ) 

Other, net

    1,539        (12,165 )      9,586        0        (1,040 ) 

 

 
    132,508        87,091        86,823        (147,963 )      158,459   

Cash Flows Provided (Used) by Investing Activities

  

     

Purchases of capital assets

    (102 )      (17,202 )      (17,923 )      0        (35,227 ) 

Proceeds from sale

         

of capital assets

    0        262        651        0        913   

Escrow deposit

    (14,000 )      0        0        0        (14,000 ) 

Acquisitions, net of

         

cash acquired

    0        (103,039 )      (708,875 )      0        (811,914 ) 

 

 
    (14,102 )      (119,979 )      (726,147 )      0        (860,228 ) 
(In thousands)                              
                Non-              
          Guarantor     Guarantor              
    Parent         Subsidiaries         Subsidiaries        Eliminations     Total  

Cash Flows Provided (Used) by Financing Activities

  

     

Proceeds provided by stock

         

issuance under employee

         

stock plans

    13,244        0        0        0        13,244   

Excess tax benefits from

         

stock options exercised

    1,830        0        0        0        1,830   

Dividends paid to non-

         

controlling interests

    0        0        (238 )      0        (238 ) 

Debt and other issuance costs

    (3,616 )      0        (1,758 )      0        (5,374 ) 

Proceeds from credit facilities

    395,000        0        0        0        395,000   

Proceeds from issuance of

         

long-term debt

    0        0        179,975        0        179,975   

Repayment of long-term debt

         

and credit facilities

    (120,313 )      (255 )      2,410        0        (118,158 ) 

Proceeds from government

         

assistance

    0        0        14,950        0        14,950   

Net change in intercompany

         

financing

    (534,804 )      35,232        351,609        147,963        0   

 

 
    (248,659 )      34,977        546,948        147,963        481,229   

Effect of foreign exchange

         

rates on cash

    1        (4 )      6,261        0        6,258   

 

 

Net increase (decrease) in

         

cash and cash equivalents

    (130,252 )      2,085        (86,115 )      0        (214,282 ) 

Cash and cash equivalents

         

– beginning of year

    205,050        2,317        214,753        0        422,120   

 

 

Cash and cash equivalents

         

– end of year

  $           74,798      $             4,402      $         128,638      $                     0      $         207,838